en

PRODUCT DETAIL

Dailiport 3 mg

Code 3000D
MA number 59/0379/19-S
Product Form: cps pld 30x1x3 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AD Calcineurin inhibitors
L04AD02 Tacrolimus
Shelf life: 24
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 03.12.2019
Pediatric warnings: Yes
SPC: SPC_Dailiport_cps pld_06-2024.pdf  
PIL: PIL_Dailiport_cps pld_06-2024.pdf  
Safety feature Yes
Data update: 31.05.2024
eu-flag.png sk-flag.png